Search research articles
Contact Us
Filters
Showing results (61-70 of 116) with videos related to
Page
of 12
Sort By:
International Journal of Antimicrobial Agents
|
September 21, 2025
A pharmacometric model assessing the in vitro synergistic effect of a bacteriophage-polymyxin B combination in a clinical multidrug-resistant Klebsiella pneumoniae isolate
Aneeq Farooq, Sue C Nang, Heidi H Yu, et al.
Microbiology Spectrum
|
December 8, 2023
Pharmacokinetic/pharmacodynamic analysis of ceftazidime/avibactam and fosfomycin combinations in an <i>in vitro</i> hollow fiber infection model against multidrug-resistant <i>Escherichia coli</i>
Niklas Kroemer, Lisa F Amann, Aneeq Farooq, et al.
Clinical Pharmacology and Therapeutics
|
April 28, 2018
Forecasting Clinical Dose-Response From Preclinical Studies in Tuberculosis Research: Translational Predictions With Rifampicin
Sebastian G Wicha, Oskar Clewe, Robin J Svensson, et al.
Antimicrobial Agents and Chemotherapy
|
April 14, 2025
PKPD modeling of the inoculum effect of combined ceftazidime/avibactam and colistin against KPC-3 <i>Klebsiella pneumoniae</i> isolate
Romain Aubry, Julien M Buyck, Alexia Chauzy, et al.
Clinical Pharmacology and Therapeutics
|
September 30, 2020
A Model Averaging/Selection Approach Improves the Predictive Performance of Model-Informed Precision Dosing: Vancomycin as a Case Study
David W Uster, Sophie L Stocker, Jane E Carland, et al.
Frontiers in Pharmacology
|
December 26, 2022
Pharmacokinetics and pharmacodynamics of anti-tuberculosis drugs: An evaluation of <i>in vitro</i>, <i>in vivo</i> methodologies and human studies
Jan-Willem C Alffenaar, Jurriaan E M de Steenwinkel, Andreas H Diacon, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
June 16, 2022
Multi-model averaging improves the performance of model-guided infliximab dosing in patients with inflammatory bowel diseases
Wannee Kantasiripitak, An Outtier, Sebastian G Wicha, et al.
International Journal of Antimicrobial Agents
|
January 30, 2021
Comparison of two empirical prolonged infusion dosing regimens for meropenem in patients with septic shock: A two-center pilot study
Albrecht Eisert, Christian Lanckohr, Janina Frey, et al.
Colloids and Surfaces. B, Biointerfaces
|
February 9, 2023
Zwitterionic surface modification of polyethylene via atmospheric plasma-induced polymerization of (vinylbenzyl-)sulfobetaine and evaluation of antifouling properties
Nils Burmeister, Christel Vollstedt, Cathrin Kröger, et al.
The Journal of Antimicrobial Chemotherapy
|
July 10, 2024
Pharmacokinetics and pharmacological target attainment of standard temocillin dosing in non-critically ill patients with complicated urinary tract infections
Gert-Jan Wijnant, Perrin Ngougni Pokem, Marie Coessens, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 116) with videos related to
Sort By:
Page
of 12
International Journal of Antimicrobial Agents
|
September 21, 2025
A pharmacometric model assessing the in vitro synergistic effect of a bacteriophage-polymyxin B combination in a clinical multidrug-resistant Klebsiella pneumoniae isolate
Aneeq Farooq, Sue C Nang, Heidi H Yu, et al.
Microbiology Spectrum
|
December 8, 2023
Pharmacokinetic/pharmacodynamic analysis of ceftazidime/avibactam and fosfomycin combinations in an <i>in vitro</i> hollow fiber infection model against multidrug-resistant <i>Escherichia coli</i>
Niklas Kroemer, Lisa F Amann, Aneeq Farooq, et al.
Clinical Pharmacology and Therapeutics
|
April 28, 2018
Forecasting Clinical Dose-Response From Preclinical Studies in Tuberculosis Research: Translational Predictions With Rifampicin
Sebastian G Wicha, Oskar Clewe, Robin J Svensson, et al.
Antimicrobial Agents and Chemotherapy
|
April 14, 2025
PKPD modeling of the inoculum effect of combined ceftazidime/avibactam and colistin against KPC-3 <i>Klebsiella pneumoniae</i> isolate
Romain Aubry, Julien M Buyck, Alexia Chauzy, et al.
Clinical Pharmacology and Therapeutics
|
September 30, 2020
A Model Averaging/Selection Approach Improves the Predictive Performance of Model-Informed Precision Dosing: Vancomycin as a Case Study
David W Uster, Sophie L Stocker, Jane E Carland, et al.
Frontiers in Pharmacology
|
December 26, 2022
Pharmacokinetics and pharmacodynamics of anti-tuberculosis drugs: An evaluation of <i>in vitro</i>, <i>in vivo</i> methodologies and human studies
Jan-Willem C Alffenaar, Jurriaan E M de Steenwinkel, Andreas H Diacon, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
June 16, 2022
Multi-model averaging improves the performance of model-guided infliximab dosing in patients with inflammatory bowel diseases
Wannee Kantasiripitak, An Outtier, Sebastian G Wicha, et al.
International Journal of Antimicrobial Agents
|
January 30, 2021
Comparison of two empirical prolonged infusion dosing regimens for meropenem in patients with septic shock: A two-center pilot study
Albrecht Eisert, Christian Lanckohr, Janina Frey, et al.
Colloids and Surfaces. B, Biointerfaces
|
February 9, 2023
Zwitterionic surface modification of polyethylene via atmospheric plasma-induced polymerization of (vinylbenzyl-)sulfobetaine and evaluation of antifouling properties
Nils Burmeister, Christel Vollstedt, Cathrin Kröger, et al.
The Journal of Antimicrobial Chemotherapy
|
July 10, 2024
Pharmacokinetics and pharmacological target attainment of standard temocillin dosing in non-critically ill patients with complicated urinary tract infections
Gert-Jan Wijnant, Perrin Ngougni Pokem, Marie Coessens, et al.
Page
of 12